Neogen Corporation

Healthcare · Medical Devices

13.80$ +0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Neogen Corporation (NEOG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 225 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NEOG
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	84	91	88	99	94	101	95	109	100	107	98	110	101	108	100	109	109	115	117	127	128	131	128	140	132	230	218	242	229	230	229	237	217	231	221	225	209	225	211	225	870
Cost of Revenue	43	47	48	52	49	52	50	60	53	57	53	59	53	57	55	57	59	62	63	70	68	70	71	75	70	117	110	119	112	113	113	123	131	142	134	133	114	118	112	118	462
Gross Profit	40	44	41	47	45	48	45	50	47	50	45	51	48	51	45	52	50	53	54	58	60	61	57	65	62	113	108	123	117	117	116	113	86	90	87	93	95	107	99	108	408
Research & Development	2.7	2.8	2.6	2.3	3.1	3.0	2.8	2.0	2.8	3.2	3.2	3.6	3.7	3.8	3.8	3.5	3.9	4.1	4.2	4.1	4.3	4.3	4.6	3.8	4.9	6.8	7.3	7.1	6.7	5.8	4.9	5.1	5.2	5.1	4.5	6.3	5.1	4.6	3.8	4.9	18
Selling, General & Administrative	8.3	8.3	8.5	9.1	9.3	10	9.3	9.2	10	10	10	10	11	11	11	12	11	12	15	13	13	23	25	22	28	77	46	50	45	52	52	51	52	58	56	53	61	65	60	59	245
Total Operating Expenses	26	27	27	28	29	30	29	30	30	32	30	32	32	33	32	32	31	34	38	37	38	48	51	47	56	120	92	100	98	102	104	96	78	73	75	106	111	112	102	105	430
Operating Income	15	17	14	19	16	18	16	20	16	18	15	19	16	18	13	20	19	19	16	20	22	12	6.4	18	6.1	-7.7	16	23	19	14	12	18	8.7	17	12	-13	-16	-5.4	-3.3	3.1	-22
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	1.0	1.3	1.4	1.5	1.3	1.6	1.6	0.7	0.6	0.3	0.0	–	0.0	0.0	0.5	0.0	21	17	18	18	18	18	19	19	18	18	17	16	15	14	14	59
Pre-Tax Income	15	17	16	19	17	19	17	20	17	20	17	19	18	19	14	21	20	19	16	20	22	13	6.6	19	6.7	-34	-2.3	7.7	1.7	-3.7	-5.8	-6.4	-16	-477	-9.7	-631	44	-20	-20	-12	-9.0
Income Tax Expense	5.3	5.6	5.4	6.5	5.3	1.9	0.7	2.4	1.9	3.7	3.6	3.7	3.0	3.0	2.1	4.8	4.0	3.5	2.6	4.4	4.7	2.1	1.2	4.0	1.5	7.8	-10	2.1	0.2	-0.3	-3.8	-1.0	-3.0	-20	1.2	-19	7.5	-4.4	-3.3	-0.8	-1.1
Net Income	9.9	11	10	12	12	17	17	18	15	16	13	16	15	16	12	16	16	16	13	16	17	11	5.4	15	5.2	-42	8.2	5.6	1.5	-3.5	-2.0	-5.4	-13	-456	-11	-612	36	-16	-17	-11	-7.9
EBITDA	19	20	19	23	21	23	22	24	21	24	21	24	22	24	19	26	25	24	22	26	27	19	13	25	12	13	43	54	49	44	43	42	33	-428	37	-584	89	23	23	37	172

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings